The group IASON produces radiopharmaceuticals and supplies special laboratory products to the target group “nuclear medicine” and “laboratory medicine”. Innovative products with the highest quality standards convince customers from all over Europe.
Our guiding principle: We acquire future-oriented products on the world market and make them accessible to the central European market. By dividing our tasks within a closely linked network of subcontractors, IASON achieves a high degree of efficiency and productivity.
The development and production of company own products play a key role within IASON. For example, IASON is currently producing immunoassays for thyroid gland diagnostics within the company. Furthermore, IASON is responsible for marketing, distribution and PR of the entire product range.
The subcontractor ARGOS produces radiopharmaceuticals for PET (Positron Emission Tomography). New PET tracers are constantly being developed into a marketable commodity in the R&D department on all locations. In the future, the existing know-how, particularly in the area of cyclotron plants, should be made accessible worldwide.